Davita inc reports qtrly adjusted net income from continuing operations per share of $1.53

. 3rd quarter 2019 results.q3 revenue $2.904 billion versus refinitiv ibes estimate of $2.85 billion.during quarter ended september 30, 2019, recognized a non-cash goodwill impairment charge of $79 million in germany kidney care business.qtrly net income from continuing operations per share $0.99.during quarter, recognized a non-cash goodwill impairment charge of $79 million in germany kidney care business.qtrly adjusted net income from continuing operations per share $1.53.qtrly earnings per share $0.95.q3 earnings per share view $1.24 -- refinitiv ibes data.davita - total u.s. dialysis treatments for q3 were 7,673,191, or an average of 97,129 treatments per day, representing a per day increase of 2.7%.sees 2019 operating cash flow from continuing operations $1,525 million to $1,675 million.sees 2020 adjusted diluted net income from continuing operations per share attributable to davita inc $5.25 - $5.75.
DVA Ratings Summary
DVA Quant Ranking